| top | |
| GLIOBLASTOMA NEWSLETTER | |
Volume 2, Number 8 -
8
April 2003 |
|
|
|
|
|
Contents |
|
|
|
|
| Diagnosis & Evaluation | |
| Etiology & Pathogenesis | |
| Integrative Medicine | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Galanaud D,
Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M, Ranjeva JP,
Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma J Neurosurg 2003 Feb;98(2):269-76 |
|
|
Vos
MJ, Uitdehaag BM, Barkhof F, Heimans JJ, Baayen HC, Boogerd W, Castelijns
JA, Elkhuizen PH, Postma TJ |
|
|
|
|
|
|
|
|
|
|
|
E.T.
Hawk ; J.L. Viner ; A. Umar ; W.F. Anderson ; C.C. Sigman ; K.Z.
Guyton Cancer and the Cyclo-oxygenase Enzyme: Implications for Treatment and Prevention American Journal of Cancer, Volume: 2 Number: 1 Page: 27 -- 55 (2003) |
|
|
Tysnes
BB, Mahesparan R Biological mechanisms of glioma invasion and potential therapeutic targets J Neurooncol 2001 Jun;53(2):129-47 |
|
|
Winking
M, Deinsberger W, Joedicke A, Boeker DK Cysteinyl-leukotriene levels in intracerebral hemorrhage: an edema-promoting factor? Cerebrovasc Dis 1998 Nov-Dec;8(6):318-26 |
|
|
|
|
|
|
|
|
|
|
|
Steinacker
J, Kroiss T, Korsh OB, Melnyk A Ukrain therapy in a frontal anaplastic grade III astrocytoma Drugs Exp Clin Res 1996;22(3-5):275-7 |
|
|
Blask
DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC Light during darkness, melatonin suppression and cancer progression Neuroendocrinol Lett 2002 Jul;23 Suppl 2:52-6 |
|
|
Sauer
LA, Dauchy RT, Blask DE Polyunsaturated fatty acids, melatonin, and cancer prevention Biochem Pharmacol 2001 Jun 15;61(12):1455-62 |
|
|
Eckert
K, Grabowska E, Stange R, Schneider U, Eschmann K, Maurer HR Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients Oncol Rep 1999 Nov-Dec;6(6):1191-9 |
|
|
Gerard G. |
|
|
|
|
|
|
|
|
|
|
|
Korones DN, Benita-Weiss M, Coyle TE, Mechtler L, Bushunow P,
Evans B, Reardon DA, Quinn JA, Friedman H Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma Cancer 2003 Apr 15;97(8):1963-8 |
|
|
Patel
VJ, Elion GB, Houghton PJ, Keir S, Pegg AE, Johnson SP, Dolan ME,
Bigner DD, Friedman HS Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft Clin Cancer Res 2000 Oct;6(10):4154-7 |
|
|
Friedman HS, Keir S, Pegg AE, Houghton PJ, Colvin OM, Moschel RC,
Bigner DD, Dolan ME O6-benzylguanine-mediated enhancement of chemotherapy Mol Cancer Ther 2002 Sep;1(11):943-8 |
|
|
Henry
S Friedman, James Pluda, Jon Weingart, Henry Brem, Brandon Evans, William
Petros, Jeremy Rich, Sandra Tourt-Uhlig, Sridharan Gururangan, David Reardon,
John Sampson, Allan Friedman, James Provenzale, Roger McLendon, O. M Colvin,
Darell D Bigner, M. E Dolan, Anthony Pegg, Robert Moschel, Jennifer Quinn Phase I trial of temodar plus O6-benzylguanine in the treatment of patients with recurrent or progressive cerebral anaplastic gliomas ASCO Proceedings, 2002 Annual Meeting, Abstract No. 311 |
|
|
Vertosick FT Jr, Selker RG, Randall MS, Kristofik MP, Rehn
T A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro J Neurooncol 1994;19(2):97-103 |
|
